169 related articles for article (PubMed ID: 28190620)
1. Propranolol treatment of infantile hemangioma is not associated with psychological problems at 7 years of age.
Moyakine AV; Spillekom-van Koulil S; van der Vleuten CJM
J Am Acad Dermatol; 2017 Jul; 77(1):105-108. PubMed ID: 28190620
[TBL] [Abstract][Full Text] [Related]
2. Propranolol treatment of infantile hemangioma (IH) is not associated with developmental risk or growth impairment at age 4 years.
Moyakine AV; Kerstjens JM; Spillekom-van Koulil S; van der Vleuten CJ
J Am Acad Dermatol; 2016 Jul; 75(1):59-63.e1. PubMed ID: 27021240
[TBL] [Abstract][Full Text] [Related]
3. Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma.
Hermans MM; Rietman AB; Schappin R; de Laat PCJ; Mendels EJ; Breur JMPJ; Langeveld HR; de Wildt SN; Breugem CC; de Graaf M; Raphael MF; Pasmans SGMA
Eur J Pediatr; 2023 Feb; 182(2):757-767. PubMed ID: 36478294
[TBL] [Abstract][Full Text] [Related]
4. Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas.
Moyakine AV; Herwegen B; van der Vleuten CJM
J Am Acad Dermatol; 2017 Nov; 77(5):868-873. PubMed ID: 28818436
[TBL] [Abstract][Full Text] [Related]
5. Mental Health of School-Aged Children Treated with Propranolol or Atenolol for Infantile Hemangioma and Their Parents.
Hermans MM; Schappin R; de Laat PCJ; Mendels EJ; Breur JMPJ; Langeveld HR; Raphael MF; de Graaf M; Breugem CC; de Wildt SN; Okkerse JME; Pasmans SGMA; Rietman AB
Dermatology; 2024; 240(2):216-225. PubMed ID: 38228125
[TBL] [Abstract][Full Text] [Related]
6. Propranolol versus captopril in the treatment of infantile hemangioma (IH): A randomized controlled trial.
Zaher H; Rasheed H; El-Komy MM; Hegazy RA; Gawdat HI; Abdel Halim DM; Abdel Hay RM; Hegazy RA; Mohy AM
J Am Acad Dermatol; 2016 Mar; 74(3):499-505. PubMed ID: 26685718
[TBL] [Abstract][Full Text] [Related]
7. The role of propranolol in the treatment of infantile hemangioma.
Laranjo S; Costa G; Paramés F; Freitas I; Martins JD; Trigo C; Pinto FF
Rev Port Cardiol; 2014 May; 33(5):289-95. PubMed ID: 24906291
[TBL] [Abstract][Full Text] [Related]
8. Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age.
Gatts JE; Rush MC; Check JF; Samelak DM; McLean TW
Pediatr Dermatol; 2022 May; 39(3):389-393. PubMed ID: 35243678
[TBL] [Abstract][Full Text] [Related]
9. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
[TBL] [Abstract][Full Text] [Related]
10. Study of Cognitive Function in Children Treated with Propranolol for Infantile Hemangioma.
González-Llorente N; Del Olmo-Benito I; Muñoz-Ollero N; Descalzo MA; García-Doval I; Torrelo A
Pediatr Dermatol; 2017 Sep; 34(5):554-558. PubMed ID: 28804922
[TBL] [Abstract][Full Text] [Related]
11. Propranolol for infantile hemangioma (PINCH): an open-label trial to assess the efficacy of propranolol for treating infantile hemangiomas and for determining the decline in heart rate to predict response to propranolol.
Sondhi V; Patnaik SK
J Pediatr Hematol Oncol; 2013 Oct; 35(7):493-9. PubMed ID: 23929318
[TBL] [Abstract][Full Text] [Related]
12. Does treatment with propranolol affect quality of life in infantile hemangioma patients and their parents?
de Wild SR; Moyakine AV; van der Vleuten CJM
Pediatr Dermatol; 2019 Nov; 36(6):958-960. PubMed ID: 31566792
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment.
Li L; Yu L; Xu Z; Wei L; Zhang B; Han X; Sun Y; Ma L
J Cosmet Dermatol; 2023 Dec; 22(12):3369-3374. PubMed ID: 37313653
[TBL] [Abstract][Full Text] [Related]
14. [Propranolol in infantile hemangiomas].
Léauté-Labrèze C
Arch Pediatr; 2015 Apr; 22(4):452-5. PubMed ID: 25753275
[TBL] [Abstract][Full Text] [Related]
15. [Infantile hemangioma: a new indication for propranolol? Retrospective study: a case-series of 25 infants].
Yilmaz L; Dangoisse C; Semaille P
Rev Med Brux; 2015; 36(1):3-9. PubMed ID: 25856965
[TBL] [Abstract][Full Text] [Related]
16. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
17. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064
[TBL] [Abstract][Full Text] [Related]
18. Late rebound of infantile hemangioma after cessation of oral propranolol.
Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
[TBL] [Abstract][Full Text] [Related]
20. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.
Hermans DJ; Bauland CG; Zweegers J; van Beynum IM; van der Vleuten CJ
Br J Dermatol; 2013 Apr; 168(4):837-43. PubMed ID: 23278381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
